At Least 1 in 5 Dementia Cases Linked to Vision Loss

by Staff Writer
September 13, 2024 at 8:06 AM UTC

A new study links impaired vision to dementia, suggesting that treating vision problems could prevent nearly 20 percent of cases.

Clinical relevance: A new study links impaired vision to dementia, suggesting that treating vision problems could prevent nearly 20 percent of cases.

  • The research, part of the National Health and Aging Trends Study (NHATS), analyzed data from 2,767 Medicare beneficiaries aged 71 and older, assessing various vision impairments.
  • Results showed that 32.2% of participants had vision impairments, with contrast sensitivity being the strongest contributor to dementia, accounting for 15% of cases.
  • The findings highlight the importance of identifying and addressing vision issues in older adults, as over 90% of vision impairments can be prevented or corrected.

While dementia rates appear to be falling, researchers remain committed to isolating factors that play a part in how and why we develop dementia. A new study – appearing in the Journal of the American Medical Association (JAMA) Ophthalmology – reveals a meaningful link between impaired vision and dementia in older Americans.

The study, the latest to come out of the National Health and Aging Trends Study (NHATS), targets visual impairments as a modifiable risk factor in preventing dementia.

Methodology

The researchers conducted a cross-sectional analysis of 2012 data that included “2,767 community-dwelling Medicare beneficiaries” who were 71 and older. The study assessed several objectively measured vision problems, including distance and near visual acuity and contrast sensitivity.

The NHATS is a longitudinal study that provides nationally representative data on older Americans. This latest analysis worked with numbers from the 11th round of NHATS, where researchers introduced objective assessments of vision. And to do that participants submitted to standardized cognitive tests, along with vision assessments through a tablet-based platform. The analysts measured dementia with an algorithm that included cognitive battery scores and self-reported physician diagnoses.

Results

The researchers found that 32.2 percent of the study participants showed some form of vision impairment, leading to a population-attributable fraction (PAF) of 19 percent for prevalent dementia. This suggests, the researchers concluded, that nearly one in five dementia cases could be avoided – potentially – if the participants had their vision problems treated.

The researchers found that contrast sensitivity was the strongest contributor to dementia prevalence, accounting for 15 percent of cases. Near visual acuity came in second at 9.7 percent and distance visual acuity ranked third at 4.9 percent.

The researchers also observed that the PAF ranked highest among:

  • 71-to-79-year-old participants – 24.3 percent.
  • Women – 26.8 percent.
  • And non-Hispanic White individuals – 22.3 percent.

What it All Means

The study results illustrate the growing need to better identify and treat vision problems as a way of mitigating dementia risk in older Americans. What makes that particularly important is that more than 90 percent of vision impairments can be prevented or corrected. So rolling out strategies to help older adults take care of their visual health could play a crucial role in stemming the tide of new dementia cases.

While this new research offers valuable insights, it still doesn’t articulate a direct causal relationship between impaired vision and dementia. As a result, the authors insist additional research could shed light on this phenomenon by investigating more diverse populations.

Further Reading

Your Chances of a Dementia Diagnosis Depend on Where You Live

Lack of Purpose in Old Age Could Hasten Dementia

Lancet Commission Identifies 2 New Modifiable Dementia Risk Factors

Original Research

Long-Term Safety, Tolerability, and Durability of Treatment Effect of Olanzapine and Samidorphan: Results of a 4-Year Open-Label Study

During up to 4 years of treatment, the combination of olanzapine/samidorphan was safe and well-tolerated, and patients’ symptoms remained stable.

Jacob S. Ballon and others

Original Research

Evolution of Treatment Modalities for Posttraumatic Stress Disorder: Top 100 Cited Articles From 1990 to 2020

The authors provide a bibliometric analysis of the most-cited articles published from 1990 to 2020 on evidence-based treatment modalities for PTSD to highlight significant developments in its understanding and management.

Mohsan Ali and others